These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34109109)
1. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling. Wu CT; Huang YC; Chen WC; Chen MF Front Oncol; 2021; 11():619365. PubMed ID: 34109109 [TBL] [Abstract][Full Text] [Related]
2. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma. Chen PT; Hsieh CC; Chen MF Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989 [TBL] [Abstract][Full Text] [Related]
3. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337 [TBL] [Abstract][Full Text] [Related]
4. The role of IL-6 in the radiation response of prostate cancer. Wu CT; Chen MF; Chen WC; Hsieh CC Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699 [TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-6 in the radiation response of liver tumors. Chen MF; Hsieh CC; Chen WC; Lai CH Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e621-30. PubMed ID: 22975618 [TBL] [Abstract][Full Text] [Related]
7. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Bao BY; Yao J; Lee YF Carcinogenesis; 2006 Sep; 27(9):1883-93. PubMed ID: 16624828 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741 [TBL] [Abstract][Full Text] [Related]
9. A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cells. Gavrilov V; Leibovich Y; Ariad S; Lavrenkov K; Shany S J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):391-4. PubMed ID: 20214985 [TBL] [Abstract][Full Text] [Related]
10. 1α,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells. Ryan ZC; Craig TA; Folmes CD; Wang X; Lanza IR; Schaible NS; Salisbury JL; Nair KS; Terzic A; Sieck GC; Kumar R J Biol Chem; 2016 Jan; 291(3):1514-28. PubMed ID: 26601949 [TBL] [Abstract][Full Text] [Related]
11. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990 [TBL] [Abstract][Full Text] [Related]
12. 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Lundqvist J; Yde CW; Lykkesfeldt AE Steroids; 2014 Jul; 85():30-5. PubMed ID: 24747771 [TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
14. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. Lehmann B; Genehr T; Knuschke P; Pietzsch J; Meurer M J Invest Dermatol; 2001 Nov; 117(5):1179-85. PubMed ID: 11710930 [TBL] [Abstract][Full Text] [Related]
15. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529 [TBL] [Abstract][Full Text] [Related]
17. Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytes. Bär M; Domaschke D; Meye A; Lehmann B; Meurer M J Invest Dermatol; 2007 Jan; 127(1):206-13. PubMed ID: 16902422 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. Krishnan AV; Peehl DM; Feldman D J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538 [TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 inhibits corneal wound healing in an ex-vivo mouse model. Sel S; Trau S; Paulsen F; Kalinski T; Stangl GI; Nass N Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):717-24. PubMed ID: 26794222 [TBL] [Abstract][Full Text] [Related]
20. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]